Roche Finance Ltd 13D and 13G filings for Eloxx Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 4:52 pm Sale | 2022-12-31 | 13G | Eloxx Pharmaceuticals, Inc. ELOX | Roche Finance Ltd | 1,893 0.100% | -123,080 (-98.49%) | Filing |
| 2022-02-14 06:18 am Purchase | 2021-12-31 | 13G | Eloxx Pharmaceuticals, Inc. ELOX | Roche Finance Ltd | 124,973 5.800% | 61,667 (+97.41%) | Filing |
| 2021-06-14 4:01 pm Purchase | 2021-04-01 | 13G | Eloxx Pharmaceuticals, Inc. ELOX | Roche Finance Ltd | 63,307 5.300% | 63,307 (New Position) | Filing |